Aberdare Ventures - Venture Capital Firm | Signal

Aberdare Ventures

Aberdare Ventures Team

View by: Table Card

INVESTORS	SWEET SPOT (RANGE)	INVESTMENT LOCATIONS	TOP INVESTMENT CATEGORIES
Paul Klingenstein Aberdare VenturesManaging Partner	$8.0M ($500K - $15.0M)	Investors in SF Bay Area (CA)	Investors in Consumer health & fitness, Investors in Consumer health & fitness, Investors in Health & hospital services, Investors in Health & hospital services, Investors in Health IT, Investors in Health IT, Investors in Medical devices, Investors in Medical devices, Investors in Pharmaceuticals, Investors in Pharmaceuticals
Sigrid Van Bladel Aberdare VenturesVenture Partner	$8.0M ($500K - $15.0M)	Investors in SF Bay Area (CA)	Investors in Consumer health & fitness, Investors in Consumer health & fitness, Investors in Health & hospital services, Investors in Health & hospital services, Investors in Health IT, Investors in Health IT, Investors in Medical devices, Investors in Medical devices, Investors in Pharmaceuticals, Investors in Pharmaceuticals

Photo of Paul Klingenstein, Managing Partner at Aberdare Ventures

Paul Klingenstein

Aberdare Ventures·Managing Partner

Sweet spot: $8.0M

Range: $500K - $15.0M

Investors in SF Bay Area (CA)

Investors in Consumer health & fitness, Investors in Consumer health & fitness, Investors in Health & hospital services, Investors in Health & hospital services, Investors in Health IT, Investors in Health IT, Investors in Medical devices, Investors in Medical devices, Investors in Pharmaceuticals, Investors in Pharmaceuticals

Photo of Sigrid Van Bladel, Venture Partner at Aberdare Ventures

Sigrid Van Bladel

Aberdare Ventures·Venture Partner

Sweet spot: $8.0M

Range: $500K - $15.0M

Investors in SF Bay Area (CA)

Investors in Consumer health & fitness, Investors in Consumer health & fitness, Investors in Health & hospital services, Investors in Health & hospital services, Investors in Health IT, Investors in Health IT, Investors in Medical devices, Investors in Medical devices, Investors in Pharmaceuticals, Investors in Pharmaceuticals